05:54 PM EST, 12/17/2024 (MT Newswires) -- AIM ImmunoTech ( AIM ) said Tuesday it received a noncompliance notice from NYSE American for failing to meet continued listing requirements.

The company said it was notified about noncompliance with the minimum required stockholders' equity for a company that has reported losses from continuing operations and net losses in its five most recent fiscal years.

AIM said the notice has no immediate impact on its listing status and does not affect its business operations or its reporting requirements with the US Securities and Exchange Commission.

The company said it has until Jan. 10 to submit a plan to regain compliance.

Shares of the company were down nearly 5% in recent after-hours activity.